-38.80(-2.25%)

-0.49(-2.72%)

-0.0050(-0.44%)

A Look At Benzinga Pro's Most-Searched Tickers For September 9, 2019

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

ACADIA Pharmaceuticals (NASDAQ: ACAD) shares were up 62.9% after the company reported its HARMONY Phase 3 Trial met its primary endpoint. Needham maintained a Buy on the stock and raised the price target from $34 to $60.

AT&T (NYSE: T) shares are up 3.1% to $37.37. Elliot Management, which holds a $3.2 billion stake in the company, sent a letter detailing his recommendations on how to make the company worth $60 per share.

FuelCell Energy (NASDAQ: FCEL) shares were up 34.9% to $0.55. The company reported better-than-expected Q3 EPS and sales results.

Cesca Therapeutics (NASDAQ: KOOL) shares were up 26.32% to $4.44 after the company entered into a global distribution agreement with ThermoGenesis to distribute its X-Series products.

PaySign (NASDAQ: PAYS) shares were down 18.7% to $9.78 after the company cut its preliminary 2019 sales guidance from $38 million-$40 million to $35-$37 million. The company cited delays in onboarding of the new plasma industry programs planned for Q1 and Q2.

Roku (NASDAQ: ROKU) shares were down 2% to $166.42. The company expanded its Roku TV licensing program in Europe.